Rhew et al., 2009 - Google Patents
Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosusRhew et al., 2009
View HTML- Document ID
- 10125430753896473015
- Author
- Rhew E
- Manzi S
- Dyer A
- Kao A
- Danchenko N
- Barinas-Mitchell E
- Sutton-Tyrrell K
- McPherson D
- Pearce W
- Edmundowicz D
- Kondos G
- Ramsey-Goldman R
- Publication year
- Publication venue
- Translational Research
External Links
Snippet
Racial differences exist in disease rates and mortality in both cardiovascular disease (CVD) and systemic lupus erythematosus (SLE). The objective of this cross-sectional study was to compare the frequency and risk factors for subclinical CVD in African American (AA) and …
- 201000000596 systemic lupus erythematosus 0 title abstract description 97
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | 25‐hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus | |
Margolis et al. | Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study | |
Fung et al. | The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets and colorectal cancer | |
Reis et al. | Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age | |
Tzoulaki et al. | Assessment of claims of improved prediction beyond the Framingham risk score | |
Eggen et al. | The sixth survey of the Tromsø study (Tromsø 6) in 2007–08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey | |
Schett et al. | High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study | |
Engström et al. | C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study | |
Stenson et al. | Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis | |
Rhew et al. | Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus | |
Selzer et al. | Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus | |
Laughlin et al. | Abdominal aortic diameter and vascular atherosclerosis: the Multi-Ethnic Study of Atherosclerosis | |
Maréchal et al. | Compliance with the faecal calprotectin test in patients with inflammatory bowel disease | |
Yan et al. | Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study | |
Blaha et al. | Providing evidence for subclinical CVD in risk assessment | |
Lertratanakul et al. | Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus | |
Hunt et al. | Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes | |
Campbell et al. | Soluble Vascular Cell Adhesion Molecule 1 and N-Terminal Pro–B-Type Natriuretic Peptide in Predicting Ischemic Stroke in Patients With Cerebrovascular Disease | |
Ix et al. | Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans: The San Diego Population Study | |
Todaro et al. | Combined effect of the metabolic syndrome and hostility on the incidence of myocardial infarction (the Normative Aging Study) | |
Cho et al. | Increased risk of coronary artery calcification progression in subjects with high baseline Lp (a) levels: The Kangbuk Samsung Health Study | |
Jorge et al. | Depression and progression of subclinical cardiovascular disease in systemic lupus erythematosus | |
Junyent et al. | Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score | |
Rizzo et al. | Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein | |
Breaux-Shropshire et al. | Prevalence of blood pressure self-monitoring, medication adherence, self-efficacy, stage of change, and blood pressure control among municipal workers with hypertension |